genenta logo positivo.png
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
October 02, 2024 06:30 ET | GENENTA SCIENCE SPA
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
mcw-logo-horz-com-tagline
Bravo Multinational, Inc. (OTC: BRVO) Announces Launch of My Charity Wireless, powered by Mobile 13
September 10, 2024 13:00 ET | Bravo Multinational Incorporated
Bravo Multinational, Inc. (BRVO) Announces Launch of My Charity Wireless, powered by Mobile 13;Paul Teutul Sr. Partners to Promote Company’s First Charity
ForgeNano_Logo_FullColor_Digital_RGB.png
Forge Battery Begins Bulk Customer Shipments of 300 Wh/kg Lithium-Ion Battery Cells
July 31, 2024 09:00 ET | Forge Nano; Forge Battery
Forge Battery prototype cells pass UN 38.3 and UL 1642 safety requirements for external sampling 21700 cylindrical cells contain >20 percent silicon, NMC 811; outperform USABC energy density...
cmi_logo.png
[Latest] Global Zero Emission Vehicle Market Size/Share Worth USD 1,136,156.9 Million by 2033 at a 18.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
July 16, 2024 12:30 ET | Custom Market Insights
Austin, TX, USA, July 16, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Zero Emission Vehicle Market Size, Trends and Insights By Vehicle Type (Battery...
Lyell_Branding_Color_RGB_102918a copy.jpg
Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion Technology
June 26, 2024 07:00 ET | Lyell Immunopharma, Inc
Dose-dependent antitumor clinical activity in ROR1+ relapsed/refractory triple-negative breast cancer; 40% objective response rate and 60% clinical benefit rate at the highest dose cleared to date...
Mindful Awards_Logo_HiRes.png
Fatty15 Nabs Prestigious 2024 Mindful Award For “Overall Supplement Product of the Year”
June 11, 2024 08:05 ET | Mindful Awards
LOS ANGELES, June 11, 2024 (GLOBE NEWSWIRE) -- The 2024 Mindful Awards Program, an independent recognition platform highlighting conscious companies and products that mindfully make waves in the...
cmi_logo.png
Latest] India Electric Vehicle Market Size/Share Worth USD 150.2 Billion by 2032 at a 25.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
March 25, 2024 15:00 ET | Custom Market Insights
Austin, TX, USA, March 26, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “India Electric Vehicle Market Size, Trends and Insights By Propulsion Type...
InsightAce.jpg
Cell Line Development Market Exclusive Report 2024-2031 | InsightAce Analytic
January 23, 2024 08:39 ET | InsightAce Analytic Pvt. LTd.
Jersey City, NJ, Jan. 23, 2024 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell Line Development Market - (By Source of Cell...
Lyell_Branding_Color_RGB_102918a copy.jpg
Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024 16:05 ET | Lyell Immunopharma, Inc
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies...
Lyell_Branding_Color_RGB_102918a copy.jpg
Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma
November 09, 2023 16:05 ET | Lyell Immunopharma, Inc
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies...